Chongqing Zhifei Bio Products Cash Flow Conversion Efficiency
Chongqing Zhifei Bio Products cash flow conversion efficiency. Based on the latest financial reports, Chongqing Zhifei Bio Products (300122) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.42 Billion ≈ $207.88 Million USD) by net assets (CN¥29.61 Billion ≈ $4.33 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Chongqing Zhifei Bio Products (2007–2025)
Cash flow conversion efficiency of Chongqing Zhifei Bio Products from 2007 to 2025. This chart illustrates how Chongqing Zhifei Bio Products's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Chongqing Zhifei Bio Products (300122) share price today for real-time trading data and today's change.
Chongqing Zhifei Bio Products Cash Flow Conversion Ratio Explained
Chongqing Zhifei Bio Products cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Chongqing Zhifei Bio Products Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chongqing Zhifei Bio Products ranked by their cash flow conversion efficiency. Also see Chongqing Zhifei Bio Products (300122) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
|
N/A |
|
Beijing Jingneng Power Co Ltd
SHG:600578
|
0.111x |
|
Clear Secure Inc
NYSE:YOU
|
1.610x |
|
Bechtle AG
XETRA:BC8
|
-0.057x |
|
Charoen Pokphand Foods Public Company Limited
BK:CPF
|
0.051x |
|
Compal Electronics Inc
TW:2324
|
-0.180x |
|
Golar LNG Limited
NASDAQ:GLNG
|
0.033x |
|
Cupid Limited
NSE:CUPID
|
0.052x |
Annual Cash Flow Conversion Efficiency for Chongqing Zhifei Bio Products (2007–2025)
The table below shows the annual cash flow conversion efficiency of Chongqing Zhifei Bio Products from 2007 to 2025. Review Chongqing Zhifei Bio Products free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥16.11 Billion ≈ $2.36 Billion |
CN¥5.17 Billion ≈ $756.14 Million |
0.321x | +324.09% |
| 2024-12-31 | CN¥30.83 Billion ≈ $4.51 Billion |
CN¥-4.41 Billion ≈ $-645.91 Million |
-0.143x | -150.14% |
| 2023-12-31 | CN¥31.51 Billion ≈ $4.61 Billion |
CN¥9.00 Billion ≈ $1.32 Billion |
0.286x | +247.93% |
| 2022-12-31 | CN¥24.24 Billion ≈ $3.55 Billion |
CN¥1.99 Billion ≈ $291.06 Million |
0.082x | -82.97% |
| 2021-12-31 | CN¥17.66 Billion ≈ $2.58 Billion |
CN¥8.51 Billion ≈ $1.24 Billion |
0.482x | +13.66% |
| 2020-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥3.50 Billion ≈ $511.68 Million |
0.424x | +78.23% |
| 2019-12-31 | CN¥5.75 Billion ≈ $841.02 Million |
CN¥1.37 Billion ≈ $200.03 Million |
0.238x | +69.81% |
| 2018-12-31 | CN¥4.18 Billion ≈ $611.80 Million |
CN¥585.59 Million ≈ $85.69 Million |
0.140x | +102.07% |
| 2017-12-31 | CN¥2.94 Billion ≈ $429.85 Million |
CN¥203.61 Million ≈ $29.79 Million |
0.069x | +94.27% |
| 2016-12-31 | CN¥2.52 Billion ≈ $368.94 Million |
CN¥89.95 Million ≈ $13.16 Million |
0.036x | -60.57% |
| 2015-12-31 | CN¥2.47 Billion ≈ $361.33 Million |
CN¥223.45 Million ≈ $32.70 Million |
0.090x | +37.81% |
| 2014-12-31 | CN¥2.46 Billion ≈ $359.64 Million |
CN¥161.39 Million ≈ $23.62 Million |
0.066x | -29.19% |
| 2013-12-31 | CN¥2.39 Billion ≈ $349.62 Million |
CN¥221.58 Million ≈ $32.42 Million |
0.093x | +94.94% |
| 2012-12-31 | CN¥2.37 Billion ≈ $347.24 Million |
CN¥112.89 Million ≈ $16.52 Million |
0.048x | -51.45% |
| 2011-12-31 | CN¥2.26 Billion ≈ $330.43 Million |
CN¥221.25 Million ≈ $32.38 Million |
0.098x | +287.24% |
| 2010-12-31 | CN¥2.14 Billion ≈ $313.40 Million |
CN¥54.19 Million ≈ $7.93 Million |
0.025x | -94.57% |
| 2009-12-31 | CN¥451.69 Million ≈ $66.10 Million |
CN¥210.61 Million ≈ $30.82 Million |
0.466x | -12.05% |
| 2008-12-31 | CN¥267.06 Million ≈ $39.08 Million |
CN¥141.58 Million ≈ $20.72 Million |
0.530x | -10.72% |
| 2007-12-31 | CN¥188.03 Million ≈ $27.52 Million |
CN¥111.66 Million ≈ $16.34 Million |
0.594x | -- |
About Chongqing Zhifei Bio Products
Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide… Read more